Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


ABIOMED INC   FYE=3 (March)

Annual - Income Statement - Standardized

Fiscal period2019201820172016201520142013201220112010
Period End Date3/31/20193/31/20183/31/20173/31/20163/31/20153/31/20143/31/20133/31/20123/31/20113/31/2010
 Sales769.43593.75445.30329.54230.31183.64158.12126.38101.1585.71
 Excise Taxes Collected (Subtracted)--------------------
 Other Revenues--------------------
 Total Revenues769.43593.75445.30329.54230.31183.64158.12126.38101.1585.71
 Cost of Goods Sold129.5798.5870.6350.4239.9537.3231.6024.5121.9822.53
 Gross Profit639.87495.17374.68279.12190.37146.32126.53101.8779.1763.18
  Depreciation--------------------
  Depreciation & Amortization--------------------
  Goodwill Amortization--------------------
  Amortization of Intangibles------------0.111.481.401.47
  Amortization of Deferred Charges--------------------
  Total Depreciation & Amortization------------0.111.481.401.47
 Interest Expense - Operating--------------------
 Interest/Investment Income - Operating--------------------
 Research & Development Expenses93.5075.3066.3949.7635.9730.7125.6527.1626.6825.95
 In-process Research & Development Expenses--------------------
  Salaries, Compensation & Labor Expense--------------------
  Stock-Based Compensation Expense--------------------
  Selling, General & Administrative Expenses321.55262.73218.15164.26125.73107.2584.2371.7162.2960.84
  Advertising Expense--------------------
  Total Selling, General & Administrative Expenses321.55262.73218.15164.26125.73107.2584.2371.7162.2960.84
 Rental Expense--------------------
 Pension/Retirement Expense--------------------
 Restructuring and Other Corporate Actions--------------------
 Operating Income (Expense) - Other--------------------
 Total Operating Expense544.62436.61355.17264.44201.65175.28141.58124.86112.34110.79
Operating Income224.81157.1490.1465.1028.678.3616.541.52(11.19)(25.08)
 Interest Expense - Non-Operating--------------------
 Interest Capitalized--------------------
 Special & Unusual Charges--------------------
 Asset Writedown and Impairments--------------------
 Restructuring Charges--------------------
 Merger & Acquisition Related Income (Expense)--------------------
 Rental Income--------------------
 Impairment of Goodwill--------------------
 Litigation--------------------
 Gain (Loss) From Sale Of Assets--------------------
 Gain (Loss) From Sale of Investments--------------1.020.00--
 Dividends of Subsidiary--------------------
 Income (Loss) from Equity Investments--------------------
 Pre-Tax Minority Interest--------------------
 Interest & Investment Income8.173.691.550.400.200.12(0.01)0.000.010.37
 Non Operating Income (Expense) - Other30.38(0.39)(0.35)0.34(0.10)0.050.330.010.316.35
 Total Non-Operating Income/Expense38.553.301.210.730.100.170.321.020.326.72
Pre-Tax Income263.36160.4491.3465.8428.778.5316.862.54(10.86)(18.35)
 Income Tax Credits--------------------
 Deferred Taxes - Total--------------------
 Income Taxes (Federal)--------------------
 Income Taxes (State)--------------------
 Income Taxes (Foreign)--------------------
 Provision for Income Taxes - Total4.3448.2739.2327.69(84.92)1.181.851.050.890.67
Income After Tax259.02112.1752.1238.15113.697.3515.011.50(11.76)(19.02)
Minority Interest--------------------
Equity in Earnings of Subsidiary--------------------
Investment Gains (Losses)--------------------
Other Income--------------------
Income from Continuing Operations259.02112.1752.1238.15113.697.3515.011.50(11.76)(19.02)
Income from Discontinued Operations--------------------
Income Before Extraordinary Income & Accounting Change259.02112.1752.1238.15113.697.3515.011.50(11.76)(19.02)
Extraordinary Income (Loss)--------------------
Cumulative Effect of Accounting Change--------------------
Consolidated Net Income (Loss)259.02112.1752.1238.15113.697.3515.011.50(11.76)(19.02)
Non-Controlling Interest--------------------
Net Income (Loss) Attributable to Parent Company259.02112.1752.1238.15113.697.3515.011.50(11.76)(19.02)
Preferred Stock Dividend & Other Adjustments------0.000.00----------
Net Income (Loss) Available to Common Shareholders259.02112.1752.1238.15113.697.3515.011.50(11.76)(19.02)
Earnings Per Share (Basic) - Cont Ops5.772.541.210.902.800.190.380.04(0.32)(0.52)
Earnings Per Share (Basic) - Disc Ops--------------------
Earnings Per Share (Basic) - Acc Change--------------------
Earnings Per Share (Basic) - Extras--------------------
Earnings Per Share (Basic) - Excluding Extraordinary Items5.772.541.210.902.800.190.380.04(0.32)(0.52)
Earnings Per Share (Basic) - Stock-Based Compensation Expense--------------------
Earnings Per Share (Basic) - Consolidated5.772.541.210.902.800.190.380.04(0.32)(0.52)
Earnings Per Share (Basic) - Parent Company5.772.541.210.902.800.190.380.04(0.32)(0.52)
Net Earnings Per Share (Basic)5.772.541.210.902.800.190.380.04(0.32)(0.52)
Earnings Per Share (Diluted) - Cont Ops5.612.451.170.852.650.180.370.04(0.32)(0.52)
Earnings Per Share (Diluted) - Disc Ops--------------------
Earnings Per Share (Diluted) - Acc Change--------------------
Earnings Per Share (Diluted) - Extras--------------------
Earnings Per Share (Diluted) - Excluding Extraordinary Items5.612.451.170.852.650.180.370.04(0.32)(0.52)
Earnings Per Share (Diluted) - Stock-Based Compensation Expense--------------------
Earnings Per Share (Diluted) - Consolidated5.612.451.170.852.650.180.370.04(0.32)(0.52)
Earnings Per Share (Diluted) - Parent Company5.612.451.170.852.650.180.370.04(0.32)(0.52)
Net Earnings Per Share (Diluted)5.612.451.170.852.650.180.370.04(0.32)(0.52)
Dilution Factor(0.11)0.160.130.01(0.11)0.140.180.11(0.14)(0.15)
Weighted Average Shares Outstanding (Basic)44.9144.1543.2442.2040.6339.3339.1138.3737.1736.88
Weighted Average Shares Outstanding (Diluted)46.1545.8544.6644.9042.8641.6141.0540.1737.1736.88
Normalized Pre-Tax Income263.36160.4491.3465.8428.778.5316.861.53(10.86)(18.35)
Normalized Income After Tax259.02112.1752.1238.15113.697.3515.010.06(11.76)(19.02)
EBITDA238.93168.1496.3468.3831.4410.8719.275.86(7.24)(20.18)
EBIT224.81157.1490.1465.1028.678.3616.541.52(11.19)(25.08)